Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

September 30, 2010

FP88 Vaccine for Multiple Sclerosis and Other Autoimmune Diseases

  • MS Research Study and Reports
    /
Thanks to Marc F., in Ft. Lauderdale, we have this to blog about: East Carolina University seeks a collaborative partner…
MS Research Study and Reports

September 29, 2010

UK News: MS doctor ‘could face legal claims’

  • Multiple Sclerosis
    /
Sept 29, 2010 A doctor struck off by the General Medical Council for exploiting vulnerable multiple sclerosis sufferers could be…
Multiple Sclerosis

September 28, 2010

Patients with multiple sclerosis who smoke appear to experience a more rapid progression of their disease

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Sept 27, 2010 Patients with multiple sclerosis who smoke appear to experience a more rapid progression of their disease, according to a…
MS Research Study and Reports

September 28, 2010

Information on Gilenya (TM), the first oral medication for MS

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
What to expect if planning to try Gilenya By Cherie C. Binns RN BS MSCN If you have been waiting…
MS Drug Therapies

September 27, 2010

Research overturns theories about MS

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Amy Corderoy September 27, 2010 The trigger for multiple sclerosis could be completely different to what scientists have believed, say…
MS Research Study and Reports

September 27, 2010

MS is no longer a contraindication for getting vaccinated with FluMist

  • Misc. MS Related
    /
September 26, 2010 UPDATE: There have been some changes in the recommendations for FluMist and people with multiple sclerosis (MS)…
Misc. MS Related

September 24, 2010

FDA Approves Gilenya (Fingolimod-FTY720) – First Oral Disease-Modifying Therapy for Relapsing MS – Expected to be available by prescription in coming weeks

  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
Sep 22, 2010 The U.S. Food and Drug Administration has approved fingolimod capsules (Gilenya,™ Novartis International AG) for reducing the…
Multiple Sclerosis

September 24, 2010

Invisible Symptoms of Multiple Sclerosis

  • For the Benefit of the Patient
    /
  • Multiple Sclerosis
    /
The National MS Society and MS Learn Online present… Invisible Symptoms in MS Part 2 A new Feature Presentation: Invisible Symptoms in…
For the Benefit of the Patient

September 23, 2010

RECENT Imaging study provides new view of multiple sclerosis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
September 23, 2010 Enlarge Researchers in Germany have gained new insight into how the immune system causes damage associated with…
MS Research Study and Reports

September 22, 2010

BREAKING MS NEWS: Novartis Gets FDA Approval For Multiple Sclerosis Drug Gilenya

  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
Sept 22, 2010 – 4:30am (RTTNews) – Novartis AG (NVS: News ) Wednesday announced that the US Food and Drug Administration approved the oral multiple…
Multiple Sclerosis

Categories

Latest Blog Posts